NeuroMetrix
MA - WoburnBiotechnology
Focus: NeuroMetrix is a neurology-focused biotech company developing transcutaneous electrical nerve stimulation (TENS) devices for pain relief and neuropathy indications. The company operates as a specialized device manufacturer with a portfolio spanning chronic pain, diabetic neuropathy, and chemotherapy-induced peripheral neuropathy.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About NeuroMetrix
AI assessmentNot HiringNo open roles listed right now. Follow NeuroMetrix to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs
ChemotherapyClinical Trials (1)
NCT01208545Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs
N/AHelp build intelligence for NeuroMetrix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.